The FDA placed a clinical hold on two Atara assets, following an inspection at a third-party site that also led to a CRL for ...

Pathogen-fighting immune cells called tissue-resident memory CD8 T cells (TRM cells) go through a surprising transformation -- and relocation -- as they fight infections in the small intestine.

Penn Medicine is one of the first institutions to develop FDA-approved CAR T-cell therapies. This therapy is currently ...

T-cell therapy, originally developed for haematological malignancies, has recently emerged as a promising therapy for ...

The first patient with relapsed/refractory acute myeloid leukemia has received KJ-C2320, an allogeneic CAR T-cell therapy ...

Researchers identify a pathogenic subset of CD8+ memory T-cells that promote airway tissue inflammation and recurrent ...

A new study has introduced an innovative approach to CAR-T therapy that could address some of the current challenges in ...

Caregiving can take many forms, often requiring a profound shift in daily life. While navigating a disease is an immense ...

The following is a summary of “Role of T cell metabolism in brain tumor development: a genetic and metabolic approach,” ...

Researchers believe the innovative idea holds immense promise for tackling a wide range of diseases including cancer through ...